Victoria Socha

DocwireNews

Anemia is among the most common complications of chronic kidney disease (CKD). Researchers in China led by Hui Wang, MD, PhD, conducted a systematic review and meta-analysis of data on the <a href="https://apm.amegroups.com/article/view/68147/html">treatment of renal anemia</a> with the oral drug, roxadustat. Results of the analysis were reported in the Annals of Palliative Medicine [2021;10(4):4726-4746].The review included a computerized search of the China Knowledge Network, VIP, Wanfang, China Biomedical, PubMed, Embase, and Cochrane Library databases. The studies of interest were published clinical randomized-controlled trials of roxadustat in the treatment of anemia in kidney disease. Inclusion and exclusion criteria called for the screening and evaluation of included studies. The meta-analysis was conducted using RevMan 5.3 software.The final analysis included seven randomized controlled trials representing 997 patients with anemia of <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/john-botson-md-rph-ccd-talks-about-new-findings-in-improving-gout-treatment/">kidney disease</a>. The meta-analysis demonstrated that compared with treatment with erythropoietin, patients in groups treated with roxadustat had significant increases in hemoglobin (mean difference [MD}, 11.70; 95% confidence interval [CI], 0.41-22.99; P=.04), hemoglobin overall response rate (odds ratio, 1.97; 95% CI, 1.7-3.33; P=.01), serum iron (standardized mean difference [SMD], 0.39; 95% CI, 0.23-0.55; P&lt;.00001), transferrin saturation (MD, 6.09; 95% CI, 5.26-6.82; P&lt;.0001), transferrin (MD, 0.36; 95% CI, 0.28-0.44; P&lt;.00001), total iron binding capacity (SMD, 0.63; 95% CI, 0.47-0.79; P&lt;.00001), and significantly reduced hepcidin (mean difference, &ndash;29.04; 95% CI, &ndash;51.61 to &ndash;6.47; P=.01).There were no statistically significant differences between the two groups in adverse reactions (OR, 1.06; 95% CI, 0.30-3.74; P=.93).&ldquo;Roxadustat can effectively improve the anemia status of patients with CKD without increasing adverse reactions. Due to limitations of the number and quality of the included studies, further verification is required through the multicenter, large sample-sized, and high quality randomized controlled trials in the future.&rdquo;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Review: Roxadustat for CKD-Related Anemia Treatment

Anemia and Kidney Disease

Anemia is among the most common complications of chronic kidney disease (CKD). Researchers in China led by Hui Wang, MD, PhD, conducted a systematic review and meta-analysis ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe